REGULATORY REVIEW: TKA Comes Off the Inpatient-Only List

Regulatory Review

TKA Comes Off the Inpatient-Only List

What are the implications for ASCs?

BY KARA NEWBURY   |  FEBRUARY 2018

Regulatory Review

In the CY 2018 OPPS/ASC proposed rule, CMS also sought responses to whether the agency should consider removing THA and PHA from the IPO list.

Regulatory Review

TKA Comes Off the Inpatient-Only List

What are the implications for ASCs?

BY KARA NEWBURY   |  FEBRUARY 2018

 

To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.

Already a member or subscriber? Sign in.

To become a member, click here. To subscribe to ASC Focus, click here.